Lista de obras - Anna Maria Malfitano - Dominio Público Uruguay

1,2-Dihydro-2-oxopyridine-3-carboxamides: The C-5 substituent is responsible for functionality switch at CB2 cannabinoid receptor

artículo científico publicado en 2014

Anandamide inhibits adhesion and migration of breast cancer cells

artículo científico publicado en 2005

Anandamide inhibits the Wnt/β-catenin signalling pathway in human breast cancer MDA MB 231 cells

artículo científico publicado en 2013

Antiangiogenic effects of N6-isopentenyladenosine, an endogenous isoprenoid end product, mediated by AMPK activation.

artículo científico publicado en 2013

Arvanil and anandamide up-regulate CD36 expression in human peripheral blood mononuclear cells

artículo científico publicado en 2007

Arvanil inhibits T lymphocyte activation and ameliorates autoimmune encephalomyelitis

artículo científico publicado en 2005

Biological and pharmacological roles of N6-isopentenyladenosine: an emerging anticancer drug

artículo científico publicado en 2008

Breast adiponcosis: a call for further research

artículo científico publicado en 2016

Cannabidiol: State of the art and new challenges for therapeutic applications

artículo científico publicado en 2017

Cannabimimetic Drugs: Recent Patents in Central Nervous System Disorders

artículo científico publicado en 2016

Cannabinoid receptor CB1 antagonists state of the art and challenges.

artículo científico publicado en 2009

Cannabinoid receptor CB1 regulates STAT3 activity and its expression dictates the responsiveness to SR141716 treatment in human glioma patients' cells

artículo científico publicado en 2015

Cannabinoids and Neuro-Inflammation: Regulation of Brain Immune Response

artículo científico publicado en 2016

Cannabinoids in the management of spasticity associated with multiple sclerosis.

artículo científico publicado en 2008

Characterization of linear mimetic peptides of Interleukin-22 from dissection of protein interfaces.

artículo científico publicado en 2017

Comment on "the negative impact of being underweight and weight loss on survival of children with acute lymphoblastic leukemia.".

artículo científico publicado en 2015

Editorial (Thematic Issue: From Old Cannabinoids to Emerging New Synthetic Derivatives with Potential Therapeutic Application in Neurological Disorders)

artículo científico publicado en 2016

Effects on immune cells of a new 1,8-naphthyridin-2-one derivative and its analogues as selective CB2 agonists: implications in multiple sclerosis

artículo científico publicado en 2013

Endocannabinoid System in Neurological Disorders.

artículo científico publicado en 2016

From anecdotal evidence of cannabinoids in multiple sclerosis to emerging new therapeutical approaches

scientific article published on 01 January 2007

From cannabis to endocannabinoids in multiple sclerosis: a paradigm of central nervous system autoimmune diseases.

artículo científico publicado en 2005

G-Quadruplex Binders Induce Immunogenic Cell Death Markers in Aggressive Breast Cancer Cells

artículo científico publicado en 2019

Immune-modulation and properties of absorption and blood brain barrier permeability of 1,8-naphthyridine derivatives

artículo científico publicado en 2013

Immuno-Modulatory Properties of a Quinolin-2-(1H)-on-3-Carboxamide Derivative: Relevance in Multiple Sclerosis.

artículo científico publicado en 2016

Immuno-Modulatory and Anti-Inflammatory Effects of Dihydrogracilin A, a Terpene Derived from the Marine Sponge Dendrilla membranosa

artículo científico publicado en 2017

Immunomodulatory properties of 1,2-dihydro-4-hydroxy-2-oxo-1,8-naphthyridine-3-carboxamide derivative VL15.

artículo científico publicado en 2017

Inhibition of 3-hydroxy-3-methylglutaryl-coenzyme A reductase activity and of Ras farnesylation mediate antitumor effects of anandamide in human breast cancer cells.

artículo científico publicado en 2010

Interaction of endocannabinoid system and steroid hormones in the control of colon cancer cell growth.

artículo científico publicado en 2012

Interactions of cisplatin analogues with lysozyme: a comparative analysis

artículo científico

Involvement of Akt/NF-κB pathway in N6-isopentenyladenosine-induced apoptosis in human breast cancer cells.

artículo científico publicado en 2010

Molecular signaling involving intrinsically disordered proteins in prostate cancer

artículo científico publicado en 2016

N6-isopentenyladenosine affects cytotoxic activity and cytokines production by IL-2 activated NK cells and exerts topical anti-inflammatory activity in mice

artículo científico publicado en 2014

N6-isopentenyladenosine improves nuclear shape in fibroblasts from humans with progeroid syndromes by inhibiting the farnesylation of prelamin A.

artículo científico publicado en 2013

N6-isopentenyladenosine, an endogenous isoprenoid end product, directly affects cytotoxic and regulatory functions of human NK cells through FDPS modulation.

artículo científico publicado en 2013

New quinolone- and 1,8-naphthyridine-3-carboxamides as selective CB2 receptor agonists with anticancer and immuno-modulatory activity

artículo científico publicado en 2015

Nucleophosmin-1 regions associated with acute myeloid leukemia interact differently with lipid membranes.

artículo científico publicado en 2018

Oxylipins from Dracontium loretense.

artículo científico publicado en 2009

Pharmacological Actions of Statins: A Critical Appraisal in the Management of Cancer ⬇️

artículo científico publicado el 21 de noviembre de 2011

Pharmacological Inhibition of WEE1 Potentiates the Antitumoral Effect of the dl922-947 Oncolytic Virus in Malignant Mesothelioma Cell Lines

scientific article published on 04 October 2020

Phytocannabinoids and Cannabimimetic Drugs: Recent Patents in Central Nervous System Disorders

artículo científico publicado en 2016

Potential therapeutic role of statins in neurological disorders.

artículo científico publicado en 2008

Rational design, synthesis and anti-proliferative properties of new CB2 selective cannabinoid receptor ligands: an investigation of the 1,8-naphthyridin-2(1H)-one scaffold.

artículo científico publicado en 2012

Rimonabant inhibits human colon cancer cell growth and reduces the formation of precancerous lesions in the mouse colon.

artículo científico publicado en 2009

Statins in neurological disorders: an overview and update.

artículo científico publicado en 2014

Structures and micelle locations of the nonlipidated and lipidated C-terminal membrane anchor of 2',3'-cyclic nucleotide-3'-phosphodiesterase

scientific article published on 13 December 2007

Synergistic inhibition of human colon cancer cell growth by the cannabinoid CB1 receptor antagonist rimonabant and oxaliplatin.

artículo científico publicado en 2010

The CB1 receptor antagonist rimonabant controls cell viability and ascitic tumour growth in mice.

artículo científico publicado en 2011

The cannabinoid CB1 receptor antagonist rimonabant (SR141716) inhibits human breast cancer cell proliferation through a lipid raft-mediated mechanism

artículo científico publicado en 2006

Tumor-Associated Macrophage Status in Cancer Treatment

scientific article published on 21 July 2020

Use of cannabinoid receptor agonists in cancer therapy as palliative and curative agents.

artículo científico publicado en 2009

What we know and do not know about the cannabinoid receptor 2 (CB2)

artículo científico publicado en 2014

p53 regulates the mevalonate pathway in human glioblastoma multiforme.

artículo científico publicado en 2015

Lista de obras de Anna Maria Malfitano

1,2-Dihydro-2-oxopyridine-3-carboxamides: The C-5 substituent is responsible for functionality switch at CB2 cannabinoid receptor

Anandamide inhibits adhesion and migration of breast cancer cells

Anandamide inhibits the Wnt/β-catenin signalling pathway in human breast cancer MDA MB 231 cells

Antiangiogenic effects of N6-isopentenyladenosine, an endogenous isoprenoid end product, mediated by AMPK activation.

Arvanil and anandamide up-regulate CD36 expression in human peripheral blood mononuclear cells

Arvanil inhibits T lymphocyte activation and ameliorates autoimmune encephalomyelitis

Biological and pharmacological roles of N6-isopentenyladenosine: an emerging anticancer drug

Breast adiponcosis: a call for further research

Cannabidiol: State of the art and new challenges for therapeutic applications

Cannabimimetic Drugs: Recent Patents in Central Nervous System Disorders

Cannabinoid receptor CB1 antagonists state of the art and challenges.

Cannabinoid receptor CB1 regulates STAT3 activity and its expression dictates the responsiveness to SR141716 treatment in human glioma patients' cells

Cannabinoids and Neuro-Inflammation: Regulation of Brain Immune Response

Cannabinoids in the management of spasticity associated with multiple sclerosis.

Characterization of linear mimetic peptides of Interleukin-22 from dissection of protein interfaces.

Comment on "the negative impact of being underweight and weight loss on survival of children with acute lymphoblastic leukemia.".

Editorial (Thematic Issue: From Old Cannabinoids to Emerging New Synthetic Derivatives with Potential Therapeutic Application in Neurological Disorders)

Effects on immune cells of a new 1,8-naphthyridin-2-one derivative and its analogues as selective CB2 agonists: implications in multiple sclerosis

Endocannabinoid System in Neurological Disorders.

From anecdotal evidence of cannabinoids in multiple sclerosis to emerging new therapeutical approaches

From cannabis to endocannabinoids in multiple sclerosis: a paradigm of central nervous system autoimmune diseases.

G-Quadruplex Binders Induce Immunogenic Cell Death Markers in Aggressive Breast Cancer Cells

Immune-modulation and properties of absorption and blood brain barrier permeability of 1,8-naphthyridine derivatives

Immuno-Modulatory Properties of a Quinolin-2-(1H)-on-3-Carboxamide Derivative: Relevance in Multiple Sclerosis.

Immuno-Modulatory and Anti-Inflammatory Effects of Dihydrogracilin A, a Terpene Derived from the Marine Sponge Dendrilla membranosa

Immunomodulatory properties of 1,2-dihydro-4-hydroxy-2-oxo-1,8-naphthyridine-3-carboxamide derivative VL15.

Inhibition of 3-hydroxy-3-methylglutaryl-coenzyme A reductase activity and of Ras farnesylation mediate antitumor effects of anandamide in human breast cancer cells.

Interaction of endocannabinoid system and steroid hormones in the control of colon cancer cell growth.

Interactions of cisplatin analogues with lysozyme: a comparative analysis

Involvement of Akt/NF-κB pathway in N6-isopentenyladenosine-induced apoptosis in human breast cancer cells.

Molecular signaling involving intrinsically disordered proteins in prostate cancer

N6-isopentenyladenosine affects cytotoxic activity and cytokines production by IL-2 activated NK cells and exerts topical anti-inflammatory activity in mice

N6-isopentenyladenosine improves nuclear shape in fibroblasts from humans with progeroid syndromes by inhibiting the farnesylation of prelamin A.

N6-isopentenyladenosine, an endogenous isoprenoid end product, directly affects cytotoxic and regulatory functions of human NK cells through FDPS modulation.

New quinolone- and 1,8-naphthyridine-3-carboxamides as selective CB2 receptor agonists with anticancer and immuno-modulatory activity

Nucleophosmin-1 regions associated with acute myeloid leukemia interact differently with lipid membranes.

Oxylipins from Dracontium loretense.

Pharmacological Actions of Statins: A Critical Appraisal in the Management of Cancer ⬇️

Pharmacological Inhibition of WEE1 Potentiates the Antitumoral Effect of the dl922-947 Oncolytic Virus in Malignant Mesothelioma Cell Lines

Phytocannabinoids and Cannabimimetic Drugs: Recent Patents in Central Nervous System Disorders

Potential therapeutic role of statins in neurological disorders.

Rational design, synthesis and anti-proliferative properties of new CB2 selective cannabinoid receptor ligands: an investigation of the 1,8-naphthyridin-2(1H)-one scaffold.

Rimonabant inhibits human colon cancer cell growth and reduces the formation of precancerous lesions in the mouse colon.

Statins in neurological disorders: an overview and update.

Structures and micelle locations of the nonlipidated and lipidated C-terminal membrane anchor of 2',3'-cyclic nucleotide-3'-phosphodiesterase

Synergistic inhibition of human colon cancer cell growth by the cannabinoid CB1 receptor antagonist rimonabant and oxaliplatin.

The CB1 receptor antagonist rimonabant controls cell viability and ascitic tumour growth in mice.

The cannabinoid CB1 receptor antagonist rimonabant (SR141716) inhibits human breast cancer cell proliferation through a lipid raft-mediated mechanism

Tumor-Associated Macrophage Status in Cancer Treatment

Use of cannabinoid receptor agonists in cancer therapy as palliative and curative agents.

What we know and do not know about the cannabinoid receptor 2 (CB2)

p53 regulates the mevalonate pathway in human glioblastoma multiforme.